NO176346C - Fremgangsmåte ved fremstilling av en flytende, vandig farmasöytisk blanding for öye- og/eller nasal administrasjon - Google Patents

Fremgangsmåte ved fremstilling av en flytende, vandig farmasöytisk blanding for öye- og/eller nasal administrasjon

Info

Publication number
NO176346C
NO176346C NO894602A NO894602A NO176346C NO 176346 C NO176346 C NO 176346C NO 894602 A NO894602 A NO 894602A NO 894602 A NO894602 A NO 894602A NO 176346 C NO176346 C NO 176346C
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
eye
preparation
nasal administration
composition
Prior art date
Application number
NO894602A
Other languages
English (en)
Norwegian (no)
Other versions
NO894602L (no
NO894602D0 (no
NO176346B (no
Inventor
Tokihiko Yamamoto
Taihei Shibazaki
Yukiyoshi Ajisawa
Ryoji Yamamoto
Yukihiko Kinoshita
Original Assignee
Kissei Pharmaceutical
Nitten Ophtalmic Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13861211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO176346(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical, Nitten Ophtalmic Research Inst filed Critical Kissei Pharmaceutical
Publication of NO894602D0 publication Critical patent/NO894602D0/no
Publication of NO894602L publication Critical patent/NO894602L/no
Publication of NO176346B publication Critical patent/NO176346B/no
Publication of NO176346C publication Critical patent/NO176346C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO894602A 1989-04-04 1989-11-17 Fremgangsmåte ved fremstilling av en flytende, vandig farmasöytisk blanding for öye- og/eller nasal administrasjon NO176346C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1085521A JPH07116029B2 (ja) 1989-04-04 1989-04-04 トラニラスト水溶液製剤

Publications (4)

Publication Number Publication Date
NO894602D0 NO894602D0 (no) 1989-11-17
NO894602L NO894602L (no) 1990-10-05
NO176346B NO176346B (no) 1994-12-12
NO176346C true NO176346C (no) 1995-03-22

Family

ID=13861211

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894602A NO176346C (no) 1989-04-04 1989-11-17 Fremgangsmåte ved fremstilling av en flytende, vandig farmasöytisk blanding for öye- og/eller nasal administrasjon

Country Status (12)

Country Link
US (1) US5356620A (fr)
EP (1) EP0391002B1 (fr)
JP (1) JPH07116029B2 (fr)
KR (1) KR940002660B1 (fr)
AT (1) ATE103808T1 (fr)
AU (1) AU623191B2 (fr)
CA (1) CA2003190C (fr)
DE (1) DE68914438T2 (fr)
DK (1) DK555089A (fr)
ES (1) ES2063146T3 (fr)
FI (1) FI95773C (fr)
NO (1) NO176346C (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
DE974350T1 (de) * 1996-02-07 2001-01-25 Kissei Pharmaceutical Co., Ltd. Tranilast enthaltendes externum und verfahren zu dessen herstellung
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
IL118657A0 (en) * 1996-06-14 1996-10-16 Arad Dorit Inhibitors for picornavirus proteases
DE69720521T2 (de) * 1996-09-28 2004-03-04 Kissei Pharmaceutical Co., Ltd., Matsumoto Hemmer der subepithelialen turbidität
NZ335042A (en) * 1996-10-14 2001-01-26 Kissei Pharmaceutical Tranilast (N-(3,4-dimethoxycinnamoyl)anthranilic acid) as a secondary cataract inhibitor
BR9807330A (pt) * 1997-02-14 2000-04-18 Kissei Pharmaceutical Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo
IL132391A0 (en) * 1997-04-18 2001-03-19 Kissei Pharmaceutical Preventives or remedies for diseases effecting excessive proliferation or retinal pigment eptihelial cells
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
US6274626B1 (en) 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
JP2001158750A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及び抗アレルギー薬の持続性向上方法
JP4541504B2 (ja) * 2000-06-14 2010-09-08 沢井製薬株式会社 トラニラストまたはその薬理学的に許容される塩を有効成分として含有する安定な水溶液製剤
WO2002055454A2 (fr) * 2001-01-10 2002-07-18 Smithkline Beecham Corporation Procede et produit
JP2011225626A (ja) * 2001-02-01 2011-11-10 Rohto Pharmaceutical Co Ltd 点眼剤
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
DE10254872A1 (de) * 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
JP2004189731A (ja) * 2002-11-26 2004-07-08 Taisho Pharmaceut Co Ltd 点鼻剤
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
JP2006306765A (ja) * 2005-04-27 2006-11-09 Nippon Tenganyaku Kenkyusho:Kk トラニラスト水性点眼液
NZ574028A (en) 2006-07-05 2010-10-29 Fibrotech Therapeutics Pty Ltd Tranilast analogues (substituted cinnamoyl anthranilate compounds) for treatment of conditions associated with firbrosis
SG10201506526QA (en) * 2007-12-21 2015-09-29 Fibrotech Therapeutics Pty Ltd Halogenated analogues of anti-fibrotic agents
EP2947073B1 (fr) 2009-10-22 2019-04-03 Fibrotech Therapeutics Pty Ltd Analogues cycliques fusionnés d'agents antifibrotiques
EP2595603A1 (fr) * 2010-07-21 2013-05-29 Alcon Research, Ltd. Composition pharmaceutique présentant des caractéristiques de solubilité améliorées
JP7191515B2 (ja) * 2017-01-17 2022-12-19 ロート製薬株式会社 眼科組成物
EP3577103A1 (fr) 2017-02-03 2019-12-11 Certa Therapeutics Pty Ltd. Composés anti-fibrotiques
JP6427244B2 (ja) * 2017-10-03 2018-11-21 ロート製薬株式会社 点眼剤
TWI651095B (zh) * 2017-10-18 2019-02-21 晶碩光學股份有限公司 具有抗敏舒緩效果的眼用產品
CN109718376B (zh) * 2017-10-27 2022-01-25 晶硕光学股份有限公司 具有抗敏舒缓效果的眼用产品
US11078155B2 (en) 2018-08-14 2021-08-03 Nuformix Technologies Limited Crystalline tranilast salts and their pharmaceutical use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296518A (fr) * 1959-04-25 1962-06-22 Véhicule liquide pour collyre
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
US4029817A (en) * 1973-09-24 1977-06-14 Allergan Pharmaceuticals Soft contact lens preserving solutions
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
US4666929A (en) * 1985-04-10 1987-05-19 Shiseido Company Ltd. Anthranilic acid ester derivatives and antiinflammatory and analgetic external preparations containing the same
CA1291036C (fr) * 1986-04-23 1991-10-22 Edwin I. Stoltz Administration de medicaments par voie nasale
KR910002669B1 (ko) * 1986-12-25 1991-05-03 데이산세이야꾸 가부시끼가이샤 서방성 과립 및 그를 함유하는 지속성 복합과립

Also Published As

Publication number Publication date
FI95773B (fi) 1995-12-15
AU623191B2 (en) 1992-05-07
DK555089D0 (da) 1989-11-07
NO894602L (no) 1990-10-05
JPH07116029B2 (ja) 1995-12-13
DE68914438D1 (de) 1994-05-11
HK1003780A1 (en) 1998-11-06
NO894602D0 (no) 1989-11-17
CA2003190C (fr) 1997-04-29
FI895492A0 (fi) 1989-11-17
KR900015722A (ko) 1990-11-10
AU4438489A (en) 1990-10-11
DE68914438T2 (de) 1994-07-28
EP0391002A3 (fr) 1991-06-26
ES2063146T3 (es) 1995-01-01
ATE103808T1 (de) 1994-04-15
JPH02264716A (ja) 1990-10-29
DK555089A (da) 1990-10-05
EP0391002A2 (fr) 1990-10-10
CA2003190A1 (fr) 1990-10-04
EP0391002B1 (fr) 1994-04-06
US5356620A (en) 1994-10-18
NO176346B (no) 1994-12-12
FI95773C (fi) 1996-03-25
KR940002660B1 (ko) 1994-03-28

Similar Documents

Publication Publication Date Title
FI95773B (fi) Menetelmä vesipitoisen, N-(3,4-dimetoksikinnamoyyli)antraniilihappoa sisältävän farmaseuttisen koostumuksen valmistamiseksi
PT93531A (pt) Processo para a preparacao de derivados de n-(3-hidroxi-4-piperidinil)(dihidrobenzofurano,dihidro-2h-benzopirano ou dihidrobenzodioxin)carboxamidas e de composicoes farmaceuticas que os contem
RO91075A (fr) Procede pour la preparation des n-heterocyclyle-bicyclique-4-piperidinamine
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
BR9006264A (pt) Derivados de aminoacidos e processo para a sua producao,medicamentos,usos de um derivado de aminoacido e processo para tratamento ou prevencao de infeccoes viroticas
AU2232288A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamides
TW266154B (fr)
IE940371L (en) Pharmaceutical compositions in the form of solutions¹containing nedocromil
HUT51622A (en) Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
RU99108789A (ru) Ингибитор субэпителиального помутнения роговицы